EMA makes 'a number of changes' to improve product information
This article was originally published in SRA
Executive Summary
The European Medicines Agency has made a number of changes to the templates that drug companies use to submit product information as part of their marketing authorization application so as to improve the way information is presented to patients, doctors and healthcare professionals on the use of these drugs once approved1.